SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently seeing significant social media activity as investors position themselves ahead of the upcoming earnings report, driven by intense speculation regarding a potential short squeeze. Community sentiment is polarized, with bullish traders highlighting recent government contract wins and defense sector growth while some skeptics express concerns over high volatility and historical earnings performance.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors ignite a massive short squeeze, fueled by stellar earnings that defied high-profile bearish bets against AI infrastructure. The community is sharply divided between retail bulls celebrating the aggressive upward momentum and critics dismissing the move as an unsustainable, hype-driven bubble.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock is a compelling value play at 52-week lows or a long-term value trap following a recent downgrade by JPMorgan and concerns over its China market reset. Community discourse is heavily polarized, with many retail traders actively averaging down to capture the 4% dividend, while others argue that the brand's lack of growth and persistent downtrend signal further downside.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing significant downward volatility as investors react to a quarterly earnings report that missed revenue and margin expectations. Despite the company's raised full-year guidance and major partnership announcements, the community is sharply divided, with bearish traders focusing on the valuation disconnect, upcoming share lockup expirations, and historical concerns, while bulls argue that its high-speed AI inference technology presents a long-term growth opportunity.

Investment Managers Series Trust II - Tradr 2X Short NBIS Daily ETF

Tradr 2X Short NBIS Daily ETF

The NBIZ ETF is seeing intense trading activity as market participants debate its effectiveness in hedging against price swings in the underlying stock, Nebius. Community sentiment is deeply divided, with many traders expressing frustration over the significant volatility and rapid decay inherent in this 2x leveraged inverse product.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending ahead of its quarterly earnings as investors monitor record-breaking organic revenue growth and high-profile government contracts that validate its commercialization path. The community is actively debating the company's valuation relative to its quantum peers and debating whether the upcoming results will trigger a significant upward move or if current price action reflects institutional accumulation.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending following a significant beat in quarterly revenue and earnings, driven by strong market adoption of YARTEMLEA and strategic debt reduction measures. The community is actively discussing the stock's potential for a short squeeze, its long-term growth prospects, and the anticipation of further milestones in the coming quarters.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as investors react to the firm's ongoing capital market activities, including share dilution and Bitcoin divestments. Sentiment remains deeply polarized, with bulls pointing to long-term treasury accumulation strategies, while bears express skepticism over the sustainability of its financial model and leadership.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending following news of a significant acquisition of Resonant Sciences for $500 million, a move aimed at scaling its defense and autonomy operations. While the company faces pressure from an accompanying $750 million at-the-market share offering, the community remains actively divided, with bulls pointing to the acquisition as a strategic expansion into high-growth defense sectors and FAA certification progress, while bears express concern over cash burn and potential shareholder dilution.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is currently a focal point for investors as the stock attempts to digest significant post-earnings volatility, with the community actively debating whether the company's strong AI-driven networking demand justifies its current valuation. While bullish sentiment centers on the long-term potential of the AI infrastructure supercycle and the company's robust forward guidance, bearish voices highlight concerns over margin contraction and the possibility that recent gains have already priced in perfection.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High?

TEM's faster growth, rising data demand and reimbursement potential strengthen the bull case, but high valuation and cash burn keep risks in focus.

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardants Board of Directors approved the granting of restricted stock units (RSUs) representing 46,044 shares of its common stock to 149 new non-executive...

Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday

Analysts change outlook & price targets for Crocs, Monolithic Power, Axos Financial, Amazon, Karyopharm, Apple, Guardant Health, Pagaya Tech.read more...

Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of -5.00% and +6.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights For the three-month period ended June 30, 2026, as compared to the same period of 2025: Reported total revenue of...

Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Canaccord Genuity 46th Annual Growth Conference in Boston, MA Fireside chat on Wednesday, August 12th at 3:00 p.m. Eastern Time Morgan...

Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of a new video featuring actor and cancer advocate Patrick Dempsey that highlights the more than 55,000 Americans who will lose their lives to colorectal cancer (CRC) this year1, a majority of which...

TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth

TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

$GH Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.90 down -12.50% YoY
• Reported revenue of $334.98M up 44.33% YoY
• Guardant Health now expects full year 2026 revenue in the range of $1.34 to $1.36 billion, representing growth of 36% to 38% compared to the prior range of $1.30 to $1.32 billion.

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Guardant Health Inc

GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection?

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$165.11
Prev Close	$165.09
Open	$165.89
Dividend Yield	0.00%
50-Day Moving Average	$148.38
Beta	1.35
Avg. Volume	2.48M
PE Ratio	-47.18

52-Week High	$176.58
52-Week Low	$53.40
Market Capitalization	$22.15B
EPS (Annual)	-$3.32
Price to Book	-98.99
Revenue Per Employee	$391,867.92

Feed

News

Sentiment

Earnings

Fundamentals

Info